Aehr Test Systems insiders sold $62.5 million and bought nothing as the stock fell 32.3% in a month
The AI burn-in darling fell 32.3% in a month on no company news, and retail is calling it a bargain. The Form 4 trail says the people closest to the company took $62.5 million off the table and bought nothing.
Vincent Jiang · 3 min read
A 24-year-old investor posted in a UK trading forum this week that Aehr Test Systems−10.61% — Aehr Test Systems, down 10.61 percent today has been "a blood bath," and that he has been "buying the dip but only have £240 left to invest" 3. The thread drew 35 points and 78 comments, and the crowd is buying the fall 3. The people running the company spent the year doing the opposite.
The fall had a name: Titan HP
Aehr makes wafer-level test and burn-in systems, the machines that stress chips for hours before they ship, and its FOX systems now serve silicon carbide power chips, memory, processors and the photonics used in AI 4. That story carried the stock from a 52-week low of $18.70 to a high of $147.40 1.
Then it dropped 19% in the week to October 19 and 32.3% over the month, and was priced at $63.33 after a 4.5% bounce that day 1. The visible catalyst, per Oppenheimer's note, was the selloff after Teradyne−10.03% — Teradyne, down 10.03 percent today launched its Titan HP+1.28% — HP, up 1.28 percent today tester 4. The company's own filing trail explains nothing: the October 19 annual-meeting 8-K holds only routine vote counts, 32,659,546 shares entitled to vote, no business news 2.
Aehr has given back more than half of its AI-year run, and sits at $63
Data
| Value | |
|---|---|
| 52-week low | 18.7 |
| Price, Oct 19 | 63.33 |
| 52-week high | 147.4 |
The receipts
GuruFocus counts $62.5 million of insider selling over the past 12 months with no insider buying, at a company that is still cash-flow negative 1. The stock now trades at a forward P/E of 83.3x against a five-year median of 39.8x, more than double its own history, and GuruFocus pegs fair value at $22.02 a share 1.
EDGAR confirms the cadence: a single filing on August 14 reported $5.2 million of insider sales, with $2.2 million on August 5, $1.2 million and $758,264 also on August 14, and more through September and October 4. The Form 4 list on EDGAR shows a steady run of insider sale filings through the second half of the year, and no open-market purchase 6.
$9.4 million of insider sales hit Form 4 in a single month
Data
| Insider sales reported | |
|---|---|
| Aug 5 | $2.2M |
| Aug 14 (a) | $5.2M |
| Aug 14 (b) | $1.2M |
| Aug 14 (c) | $0.76M |
The counterpoint, stated fairly
Oppenheimer, which initiated coverage at Outperform with a $120 target in September, called the post-Titan HP decline a buying opportunity on October 14; Jefferies−0.20% — Jefferies, down 0.20 percent today opened at Buy with a $175 target in August; and Aehr booked a $6 million AI chip testing order on October 7 and a $22 million follow-on order in August 4. The consensus of six analysts is Buy with a $128 average target, roughly double the current price 4. That is the bull case, and it is not thin.
But watch who is acting on which side of it. The analysts put names and targets on paper; the insiders took $62.5 million off the table at prices above today's 1. The annual-meeting 8-K, the one mandatory public window into the company that week, added nothing 2. The record shows one trade with conviction, and it was not the buy side.
November 2 is the reading that matters
Aehr reports fiscal first-quarter results on November 2 4. That is where the AI order momentum either appears in revenue or does not. Until it does, a bounce off $63 is retail flow, not insider conviction 4.
Get Chips by email, free
How AI demand is reshaping chipmakers, memory and the fabs behind them. In our daily email, every weekday.
